James Streisand

No open positions remaining

69 year

Health Technology

Finance

Consumer Services

Profile

James Streisand worked at Genzyme Corp.
from 1998 to 2011, including the role of Vice President-Clinical Research in 2011.
Dr. Streisand worked at Sanofi from 2011 to 2013 as Vice President-Clinical Development in 2013.
Dr. Streisand worked at rEVO Biologics, Inc. as Vice President-Clinical Development.
Dr. Streisand completed undergraduate education at Massachusetts Institute of Technology and earned a doctorate from State University of New York at Buffalo.

Former positions of James Streisand

Companies	Position	End
SANOFI	Corporate Officer/Principal	31/05/2013
Genzyme Corp. Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology	Corporate Officer/Principal	31/03/2011
REVO BIOLOGICS INC	Chief Tech/Sci/R&D Officer	-

See the detail of James Streisand's experience

Training of James Streisand

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of James Streisand's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	5
Genzyme Corp. Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology	Health Technology
Sanofi Sanofi Pharmaceuticals: MajorHealth Technology Engages in research, development and production of pharmaceuticals & vaccines	Health Technology
Massachusetts Institute of Technology Massachusetts Institute of Technology Finance/Rental/LeasingFinance Functions as a College/University	Finance
State University of New York at Buffalo State University of New York at Buffalo Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
rEVO Biologics, Inc. rEVO Biologics, Inc. BiotechnologyHealth Technology Develops and commercializes specialty therapeutics to address unmet medical needs in patients with rare, life-threatening conditions	Health Technology